Effects of raloxifene on development of the methotrexate-induced changes in bone mechanical properties of male rats.
Journal Title: Pharmacological Reports - Year 2007, Vol 59, Issue 3
Abstract
Methotrexate, a cytostatic and immunosuppressive drug, has been reported to deteriorate the osseous system. Raloxifene, a selective estrogen receptor modulator, is used in the prevention and treatment of postmenopausal osteoporosis. There is a lack of data on possible ways of preventing the unwanted skeletal effects of prolonged immunosuppressive therapy. The aim of the present study was to investigate the effects of raloxifene on mechanical properties of the femur in male rats administered methotrexate. The experiments were carried out on mature male Wistar rats, which were divided into 6 groups: controls, rats administered raloxifene hydrochloride (5 mg/kg po), rats administered methotrexate (0.5 mg/kg po or im), and rats administered raloxifene hydrochloride (5 mg/kg po) plus methotrexate (0.5 mg/kg po or im). Raloxifene was administered for 28 days and methothrexate was administered for the first 10 days of the experiment. After 28 days of drug administration, mechanical parameters of the whole femur were determined: the extrinsic stiffness, the ultimate load and the breaking load, deformation caused by the ultimate and breaking loads, and the load causing fracture of the femoral neck. Additionally, the mass of isolated femurs and their mineral and calcium content were determined. Intragastrically or intramuscularly administered methotrexate impaired the endurance of the tested bones. Administration of raloxifene alone had no significant effects on the mechanical parameters of the femur. Administration of raloxifene resulted in a reduction of the adverse changes in the osseous system induced by methotrexate. Concluding, the experiments demonstrated a protective action of raloxifene against the effects of methotrexate on the osseous system in male rats.
Authors and Affiliations
Barbara Nowińska, Urszula Cegieła, Joanna Folwarczna, Leszek Śliwiński, Ilona Kaczmarczyk-Sedlak, Maria Pytlik, Waldemar Janiec
Keywords
Related Articles
- EP ID EP83930
- DOI -
- Views 106
- Downloads 0
Effects of single and repeated in vitro exposure of three forms of parabens, methyl-, butyl- and propylparabens on the proliferation and estradiol secretion in MCF-7 and MCF-10A cells.
Background: Here, we analyzed the dose- (0.2, 2, 20, 200 nM or 2 μM) and time- (48, 96, 144 and 196 h) dependent activity of a single or repeated exposure of methyl-, butyl- and propylparaben on the proliferation of MCF-...
Effect of ESR1 and ESR2 gene polymorphisms on rheumatoid arthritis treatment with methotrexate.
Rheumatoid arthritis (RA) is a complex autoimmune disease with clinical prevalence in women. Moreover, women have poorer response to treatment than men. Possible reasons for gender differences in response to treatment co...
Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells.
Parthenolide is a major sesquiterpene lactone derived from feverfew (Tanacetum parthenium) with known anti-inflammatory activity. Moreover, the anticancer potential of this compound was suggested. In this study, we deter...
Role of NF-kappaB in the pathogenesis of diabetes and its associated complications.
The nuclear factor-kappaB (NF-kappaB) family is comprised of DNA-binding protein factors that are required for the transcription of most proinflammatory molecules, including adhesion molecules, enzymes, cytokines, and ch...
Dual effects of heparin on BMP-2-induced osteogenic activity in MC3T3-E1 cells.
Heparin displays several types of biological activities by binding to various extracellular molecules, including pivotal roles in bone metabolism. We have previously reported that heparin competitively inhibits the bindi...